1. Home
  2. NPO vs CRSP Comparison

NPO vs CRSP Comparison

Compare NPO & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPO
  • CRSP
  • Stock Information
  • Founded
  • NPO 2002
  • CRSP 2013
  • Country
  • NPO United States
  • CRSP Switzerland
  • Employees
  • NPO N/A
  • CRSP N/A
  • Industry
  • NPO Metal Fabrications
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NPO Industrials
  • CRSP Health Care
  • Exchange
  • NPO Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • NPO 3.7B
  • CRSP 3.4B
  • IPO Year
  • NPO N/A
  • CRSP 2016
  • Fundamental
  • Price
  • NPO $200.18
  • CRSP $47.87
  • Analyst Decision
  • NPO Buy
  • CRSP Buy
  • Analyst Count
  • NPO 2
  • CRSP 21
  • Target Price
  • NPO $217.50
  • CRSP $75.42
  • AVG Volume (30 Days)
  • NPO 116.7K
  • CRSP 2.7M
  • Earning Date
  • NPO 02-19-2025
  • CRSP 02-11-2025
  • Dividend Yield
  • NPO 0.60%
  • CRSP N/A
  • EPS Growth
  • NPO 227.68
  • CRSP N/A
  • EPS
  • NPO 3.45
  • CRSP N/A
  • Revenue
  • NPO $1,048,700,000.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • NPO N/A
  • CRSP $227.76
  • Revenue Next Year
  • NPO $3.43
  • CRSP $353.05
  • P/E Ratio
  • NPO $59.97
  • CRSP N/A
  • Revenue Growth
  • NPO N/A
  • CRSP N/A
  • 52 Week Low
  • NPO $136.68
  • CRSP $36.52
  • 52 Week High
  • NPO $214.58
  • CRSP $90.62
  • Technical
  • Relative Strength Index (RSI)
  • NPO 64.39
  • CRSP 58.27
  • Support Level
  • NPO $186.32
  • CRSP $38.28
  • Resistance Level
  • NPO $214.58
  • CRSP $55.88
  • Average True Range (ATR)
  • NPO 4.37
  • CRSP 2.87
  • MACD
  • NPO 1.47
  • CRSP 1.07
  • Stochastic Oscillator
  • NPO 56.72
  • CRSP 54.50

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which manufactures and markets sealing products, wheel-end components & systems, and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: